The court denied plaintiff's motion to extend the statutory 30-month stay of FDA approval, rejecting plaintiff's suggestion that defendant's unsuccessful and later withdrawn motion to dismiss for lack of personal jurisdiction "unreasonably prolonged the litigation." "While [a defendant's] motion to dismiss was pending for three months before its withdrawal, [plaintiff] has offered no evidence that the mere submission of this motion -- or the limited jurisdictional discovery that the parties conducted -- caused any significant delay in these proceedings. [Plaintiff] has not sought to expedite this litigation."
Bayer Schering Pharma AG et al. v. Sandoz, Inc. et al., 1-08-cv-03710 (NYSD September 2, 2010, Memorandum Opinion & Order) (Gardephe, J.)